Robert W. Baird Issues Pessimistic Forecast for Healthpeak Properties (NYSE:DOC) Stock Price

Healthpeak Properties (NYSE:DOC) had its price objective lowered by stock analysts at Robert W. Baird from $25.00 to $24.00 in a research report issued on Tuesday,Benzinga reports. The firm currently has an “outperform” rating on the real estate investment trust’s stock. Robert W. Baird’s price target suggests a potential upside of 23.27% from the company’s current price.

A number of other research firms have also weighed in on DOC. Morgan Stanley upgraded shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price objective for the company in a research note on Wednesday, January 15th. Wells Fargo & Company dropped their price target on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 10th. Mizuho dropped their price target on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a report on Thursday, December 5th. Royal Bank of Canada raised their price target on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Finally, StockNews.com downgraded shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Wednesday, October 30th. One analyst has rated the stock with a sell rating, three have given a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $24.08.

Healthpeak Properties Stock Down 0.7 %

NYSE:DOC opened at $19.47 on Tuesday. The firm has a market cap of $13.62 billion, a P/E ratio of 55.63, a P/E/G ratio of 2.18 and a beta of 1.15. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.31 and a current ratio of 1.35. Healthpeak Properties has a fifty-two week low of $16.01 and a fifty-two week high of $23.26. The firm has a 50-day simple moving average of $20.46 and a two-hundred day simple moving average of $21.50.

Hedge Funds Weigh In On Healthpeak Properties

A number of institutional investors and hedge funds have recently made changes to their positions in the business. State Street Corp purchased a new position in shares of Healthpeak Properties in the third quarter worth approximately $1,093,576,000. JPMorgan Chase & Co. boosted its holdings in shares of Healthpeak Properties by 23.2% in the third quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock worth $493,115,000 after buying an additional 4,056,931 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Healthpeak Properties by 3.6% during the fourth quarter. Geode Capital Management LLC now owns 18,355,772 shares of the real estate investment trust’s stock valued at $371,168,000 after purchasing an additional 638,012 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in Healthpeak Properties by 2,113.5% during the fourth quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust’s stock valued at $367,575,000 after purchasing an additional 17,314,572 shares in the last quarter. Finally, Centersquare Investment Management LLC lifted its holdings in Healthpeak Properties by 3.7% during the fourth quarter. Centersquare Investment Management LLC now owns 11,215,516 shares of the real estate investment trust’s stock valued at $227,339,000 after purchasing an additional 398,770 shares in the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.